However, in obesity and NAFLD, a defective FXR-SHP cascade results in increased AHR occupancy at the miR-802 promoter and increased miR-802 gene expression (Fig. 3A). This evidence concerns the gene NR0B2 and metabolic dysfunction-associated steatotic liver disease.